THIRD MOLAR REMOVING
Conditions
Interventions
Trade Name: Articaina-epinefrina
Product Name: Articaina-Epinefrina
Product Code: Ultracain
Pharmaceutical Form: Injection
Trade Name: Dexametasona
Product Name: Dexametasona
Product Code: Dexametaso
Sponsors
Complejo Hospitalario Torrecárdenas
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. ADULT PATIENTS BETWEEN 18-45 YEARS OLD, AGE RANGE IN THAT USUALLY , THE THIRD MOLAR EMERGE OR PRODUCE THE DIFFERENT PÀTOLOGIES DERIVATES OF INCOMPLETE OR NOT ,EMERGING OF THIS ONE. 2. MEN AND WOMEN WIL BE SELECTED. 3 ONLY ONE PROCEDURE BY ONLY ONE SURGICAL ACT, I.E.,ONLY ONE EXTRACTION FOR EACH PATIENT AND INCIDENT. 4 PROCEDURE DONE UNDER LOCAL ANESTHESIA. 5 PATIENTS WHO HAVE AUTHORIZED THIRD REMOVING, SIGNING THE PATIENT INFORMATION FORM. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 66 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: 1.PATIENTS UNDER 18 OR HIGHER 46 YEARS OLD. 2. MULTIPLE PROCEDURE, I.E., MORE THAN ONE EXTRACTION IN THE SAME SURGICAL ACT. 3 ANTICOAGULATED PATIENTS. 4. PATIENTS UNDER ONCOLOGICAL TREATMENT. 5. PATIENTS UNDER BISPHOSPHONATES TREATMENT 6. PATIENTS WTITH SISTEMIC PATHOLOGY THAT SHOULD BE PRODUCED INTERFERENCES WITH THE RESULT. 7. THIRD MOLAR WITH ODONTOGENIC CYST ASSOCIATES. 8. PATIENTS WHO HAVE RECIVIED LOCOREGIONAL RADIOTHERAPIC TREATMENT 9. PREVIOUS SURGERY IN THE INFERIOR RETROMOLAR TRIANGULE. 10 MENTAL DISSABILITY PATIENTS 11. PATIENETSWHO HAVE BEEN OPERATED UNDER GENERAL ANESTHESIA OR SEDATTION. 12. PRESENCE OF ACTIVE DISCHARGE INFECTION IN THE TIME OF SURGERY 13 PATIENTS WITH ALLERGIES AND/OR INTOLERANCE TO THE DRUGS THAT THIS STUDY USES. 14. PATIENTS WHO HAVE ALLERGIES TO BETALACTAMICS OR NSAID. 15. PREGNANT WOMEN OR WITH POSSIBILITY ( CHECKED WITH PREGNANT TEST) 16. PATIENTS WHO DON´T WANT, AUTHORIZE TO ENJOY IN THE STUDY OR NOT UNTHERSTAND THE SPANISH LANGUAGE. 17 ANY MEDICAL OR SURGICAL CONDITION THAT , UNDER THE RESEARCHER JUDGMENT, PUTS THE PATIENT UNDER DANGER SITUATION OR TO PREVENT THE PATIENT DON´T MEET THE REQUERIMENTS OR FINISH THE STUDY.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: TO EVALUATE THE EFFECT AND THE SECURITY OF ARTICAINE-EPINEFRINE, BIPIVACAINE+DEXAMETASONE( THOSE LAST ONE ASSOCIATES ) AGAINST ARTICAINE-EPINEFRINE IN THE CONTROL OF POSTQUIRURGICAL PAIN AFTER THE INFERIOR THIRD MOLAR SURGERY;Secondary Objective: NOT APPLICABLE;Primary end point(s): TO EVALUATE THE EFFECT AND THE SECURITY OF ARTICAINE-EPINEFRINE, BIPIVACAINE+DEXAMETASONE( THOSE LAST ONE ASSOCIATES ) AGAINST ARTICAINE-EPINEFRINE IN THE CONTROL OF POSTQUIRURGICAL PAIN AFTER THE INFERIOR THIRD MOLAR SURGERY.;Timepoint(s) of evaluation of this end point: 24 HOURS | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): NOT APPLICABLE;Timepoint(s) of evaluation of this end point: NOT APPLICABLE | — |
Countries
Spain
Contacts
Public ContactFIBAO
FIBAO
Outcome results
None listed